Skip to main content
Figure 1 | Journal of Medical Case Reports

Figure 1

From: A combination of bortezomib and rituximab yields a dramatic response in a woman with highly refractory immune thrombocytopenic purpura: a case report

Figure 1

Trend in platelet counts during treatment. The y-axis depicts platelet counts in thousands/mm3 and the timeline is plotted on the x-axis. The star indicates the time of the intracranial bleed. The dark bar shows the duration of bortezomib treatment and arrows indicate timing of the injections; the lighter bar shows the duration of rituximab treatment with arrows indicating the timing of the treatments.

Back to article page